NPI: 1255360384 · CHERRY HILL, NJ 08034 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/01/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/01/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,641 | $1.17M |
| 2019 | 13,542 | $638K |
| 2020 | 11,808 | $609K |
| 2021 | 13,452 | $524K |
| 2022 | 24,392 | $542K |
| 2023 | 22,414 | $840K |
| 2024 | 7,142 | $600K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 39,995 | 2,885 | $4.39M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,683 | 1,375 | $261K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,473 | 1,229 | $127K |
| A4657 | Syringe, with or without needle, each | 9,104 | 2,282 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 5,931 | 1,442 | $25K |
| 82728 | 1,809 | 1,279 | $17K | |
| 83540 | 1,902 | 1,302 | $17K | |
| 83550 | 987 | 831 | $17K | |
| 83970 | 1,641 | 1,116 | $13K | |
| 85048 | 1,688 | 1,149 | $10K | |
| 85041 | 1,707 | 1,156 | $9K | |
| 82108 | 358 | 260 | $5K | |
| 82607 | 80 | 64 | $2K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,366 | 588 | $71.34 |
| 0124A | 18 | 12 | $40.00 | |
| G0008 | Administration of influenza virus vaccine | 160 | 118 | $37.94 |
| 90670 | 19 | 19 | $14.94 | |
| 90674 | 105 | 76 | $4.42 | |
| G0009 | Administration of pneumococcal vaccine | 19 | 19 | $1.51 |
| OP250 | 9,052 | 265 | $1.00 | |
| 0002A | 20 | 16 | $0.00 | |
| 0004A | 26 | 15 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 248 | 100 | $0.00 |